Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients

le Knutson, Keith L., Schiffman, Kathy, Disis, Mary L.
Foilsithe 2001

Cytokine and neuropeptide levels are associated with pain relief in patients with chronically painful total knee arthroplasty: a pilot study

le Singh, Jasvinder A., Noorbaloochi, Siamak, Knutson, Keith L.
Foilsithe in BMC Musculoskelet Disord (2017)

Therapeutic vaccines for malignant brain tumors

le Gustafson, Michael P, Knutson, Keith L, Dietz, Allan B
Foilsithe 2008

Immune promotion of epithelial-mesenchymal transition and generation of breast cancer stem cells

le Reiman, Jennifer M., Knutson, Keith L., Radisky, Derek C.
Foilsithe 2010

Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System

le Erskine, Courtney L., Henle, Andrea M., Knutson, Keith L.
Foilsithe 2012

Targeted Immune Therapy of Ovarian Cancer

le Knutson, Keith L., Karyampudi, Lavakumar, Lamichhane, Purushottam, Preston, Claudia
Foilsithe in Cancer Metastasis Rev (2015)

Tumor Immunoediting and Immunosculpting Pathways to Cancer Progression

le Reiman, Jennifer M., Kmieciak, Maciej, Manjili, Masoud H., Knutson, Keith L.
Foilsithe 2007

HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses

le Kmieciak, Maciej, Knutson, Keith L., Dumur, Catherine I., Manjili, Masoud H.
Foilsithe 2007

TUMOR-INFILTRATING DENDRITIC CELLS IN CANCER PATHOGENESIS(1)

le Janco, Jo Marie Tran, Lamichhane, Purushottam, Karyampudi, Lavakumar, Knutson, Keith L.
Foilsithe in J Immunol (2015)

Breast cancer vaccines: maximizing peptide-based vaccines by regulatory T cell depletion and toll-like receptor 9 activation

le Nava-Parada, Pilar, Herron, Adam, Knutson, Keith L, Pease, Larry, Celis, Esteban
Foilsithe 2007

Peptide Vaccine Administered with a Toll-like Receptor Agonist is Effective for the Treatment and Prevention of Spontaneous Breast Tumors

le Nava-Parada, Pilar, Forni, Guido, Knutson, Keith L., Pease, Larry R., Celis, Esteban
Foilsithe 2007

Downregulation of TAP1 and TAP2 in early stage breast cancer

le Henle, Andrea M., Nassar, Aziza, Puglisi-Knutson, Danell, Youssef, Bahaaeldin, Knutson, Keith L.
Foilsithe in PLoS One (2017)

GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b−Gr1− bone marrow progenitor cells into myeloid-derived suppressor cells

le Morales, Johanna K., Kmieciak, Maciej, Knutson, Keith L., Bear, Harry D., Manjili, Masoud H.
Foilsithe 2009

Tumor Escape and Progression under Immune Pressure

le Manjili, Masoud H., Egilmez, Nejat, Knutson, Keith L., Selvan, Senthamil R., Ostberg, Julie R.
Foilsithe 2012

Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells

le Henle, Andrea M., Erskine, Courtney L., Benson, Linda M., Clynes, Raphael, Knutson, Keith L.
Foilsithe 2012

The Immune System in the Pathogenesis of Ovarian Cancer

le Charbonneau, Bridget, Goode, Ellen L., Kalli, Kimberly R., Knutson, Keith L., DeRycke, Melissa S.
Foilsithe 2013

Cancer immunotherapy beyond immune checkpoint inhibitors

le Marin-Acevedo, Julian A., Soyano, Aixa E., Dholaria, Bhagirathbhai, Knutson, Keith L., Lou, Yanyan
Foilsithe in J Hematol Oncol (2018)

1α,25-Dihydroxyvitamin D(3)–Induced Myeloid Cell Differentiation Is Regulated by a Vitamin D Receptor–Phosphatidylinositol 3-Kinase Signaling Complex

le Hmama, Zakaria, Nandan, Devki, Sly, Laura, Knutson, Keith L., Herrera-Velit, Patricia, Reiner, Neil E.
Foilsithe 1999

TGFβ/TNFα-Mediated Epithelial-Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype

le Asiedu, Michael K., Ingle, James N., Behrens, Marshall D., Radisky, Derek C., Knutson, Keith L.
Foilsithe 2011

Immunity and immune suppression in human ovarian cancer

le Preston, Claudia C, Goode, Ellen L, Hartmann, Lynn C, Kalli, Kimberly R, Knutson, Keith L
Foilsithe 2011